Aquestive Therapeutics Inc

NASDAQ:AQST   4:00:00 PM EDT
2.26
-0.05 (-2.16%)
: $2.24 -0.02 (-0.89%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)123.66M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$10.92 Million
Adjusted EPS-$0.12
See more estimates
10-Day MA$2.24
50-Day MA$1.65
200-Day MA$1.15
See more pivots

Aquestive Therapeutics Inc Stock, NASDAQ:AQST

30 Technology Drive, Warren, New Jersey 07059
United States of America
Phone: +1.908.941.1900
Number of Employees: 130

Description

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients� therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.